AVALON GLOBOCARE CORP (AVCO) Stock Price, Forecast & Analysis
USA - NASDAQ:AVCO - US05344R1041 - Common Stock
AVCO Key Statistics, Chart & Performance
The current stock price of AVCO is 0.5259 USD. In the past month the price increased by 4.7%. In the past year, price decreased by -49.43%.
AVCO Latest News, Press Relases and Analysis
AVCO Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LB | LANDBRIDGE CO LLC-A | 62.31 | 5.29B | ||
| KW | KENNEDY-WILSON HOLDINGS INC | N/A | 1.30B | ||
| FRPH | FRP HOLDINGS INC | 68.5 | 445.07M | ||
| TCI | TRANSCONTINENTAL REALTY INV | 61.21 | 401.93M | ||
| SEG | SEAPORT ENTERTAINMENT GROUP | N/A | 296.35M | ||
| MLP | MAUI LAND & PINEAPPLE CO | N/A | 293.53M | ||
| ARL | AMERICAN REALTY INVESTORS IN | N/A | 267.28M | ||
| OZ | BELPOINTE PREP LLC | N/A | 245.07M | ||
| SRG | SERITAGE GROWTH PROP- A | N/A | 226.97M | ||
| NEN | NEW ENGLAND REALTY ASSOC-LP | 0.51 | 196.00M | ||
| LPA | LOGISTIC PROPERTIES OF THE A | 14.05 | 98.57M | ||
| INTG | INTERGROUP CORP | N/A | 77.51M |
Related stock screener links
About AVCO
Company Profile
Avalon GloboCare Corp. is a holding company, which engages in the development of biotechnology and the provision of healthcare services. The company is headquartered in Freehold, New Jersey and currently employs 5 full-time employees. The company went IPO on 2016-02-22. The firm provides immune effector cell therapy, exosome technology, as well as COVID-19 related diagnostics, and therapeutics. The company operates through two segments: real property and medical related consulting services. Its major clinical programs include AVA-001, AVA-011 and FLASH-CAR, ACTEX, and AVA-Trap. The company also provides strategic advisory and outsourcing services to facilitate and enhance its client's growth and development, as well as competitiveness in healthcare and CellTech industry markets. Its downstream medical team and facility consists of affiliated hospital networks and experts specialized in hematology, oncology, cellular immunotherapy, hematopoietic stem/progenitor cell transplant, as well as regenerative therapeutics. Its services include research studies, executive education, daily online executive briefings, expert advisory services, and consulting and management services.
Company Info
AVALON GLOBOCARE CORP
4400 ROUTE 9, SUITE 3100
Freehold NEW JERSEY 07728 US
CEO: David Jin
Employees: 5
Phone: 17327804400.0
AVALON GLOBOCARE CORP / AVCO FAQ
What does AVALON GLOBOCARE CORP do?
Avalon GloboCare Corp. is a holding company, which engages in the development of biotechnology and the provision of healthcare services. The company is headquartered in Freehold, New Jersey and currently employs 5 full-time employees. The company went IPO on 2016-02-22. The firm provides immune effector cell therapy, exosome technology, as well as COVID-19 related diagnostics, and therapeutics. The company operates through two segments: real property and medical related consulting services. Its major clinical programs include AVA-001, AVA-011 and FLASH-CAR, ACTEX, and AVA-Trap. The company also provides strategic advisory and outsourcing services to facilitate and enhance its client's growth and development, as well as competitiveness in healthcare and CellTech industry markets. Its downstream medical team and facility consists of affiliated hospital networks and experts specialized in hematology, oncology, cellular immunotherapy, hematopoietic stem/progenitor cell transplant, as well as regenerative therapeutics. Its services include research studies, executive education, daily online executive briefings, expert advisory services, and consulting and management services.
What is the current price of AVCO stock?
The current stock price of AVCO is 0.5259 USD. The price decreased by -16.52% in the last trading session.
What is the dividend status of AVALON GLOBOCARE CORP?
AVCO does not pay a dividend.
How is the ChartMill rating for AVALON GLOBOCARE CORP?
AVCO has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Can you provide the number of employees for AVALON GLOBOCARE CORP?
AVALON GLOBOCARE CORP (AVCO) currently has 5 employees.
Can you provide the upcoming earnings date for AVALON GLOBOCARE CORP?
AVALON GLOBOCARE CORP (AVCO) will report earnings on 2022-11-22, after the market close.
AVCO Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to AVCO. When comparing the yearly performance of all stocks, AVCO is a bad performer in the overall market: 80.4% of all stocks are doing better.
AVCO Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to AVCO. Both the profitability and financial health of AVCO have multiple concerns.
AVCO Financial Highlights
Over the last trailing twelve months AVCO reported a non-GAAP Earnings per Share(EPS) of -0.1. The EPS increased by 27.93% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -600.07% | ||
| ROA | -82.31% | ||
| ROE | N/A | ||
| Debt/Equity | 14 |